“Let the Sunshine In”: The Impact of Industry Payment Disclosure on Physician Prescription Behavior

References

• Abadie A, Diamond A, Hainmueller J (2010) Synthetic control methods for comparative case studies: Estimating the effect of California’s tobacco control program. J. Amer. Statist. Assoc. 105(490):493–505.Crossref, Google Scholar
• Abadie A, Diamond A, Hainmueller J (2015) Comparative politics and the synthetic control method. Amer. J. Political Sci. 59(2):495–510.Crossref, Google Scholar
• Agrawal S, Brennan N, Budetti P (2013) The sunshine act—Effects on physicians. New England J. Medicine 368(22):2054–2057.Crossref, Google Scholar
• Cain DM, Loewenstein G, Moore DA (2005) The dirt on coming clean: Perverse effects of disclosing conflicts of interest. J. Legal Stud. 34(1):1–25.Crossref, Google Scholar
• Cain DM, Loewenstein G, Moore DA (2011) When sunlight fails to disinfect: Understanding the perverse effects of disclosing conflicts of interest. J. Consumer Res. 37(5):836–857.Crossref, Google Scholar
• Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D (2007) A national survey of physician–industry relationships. New England J. Medicine 356(17):1742–1750.Crossref, Google Scholar
• Campbell SM (2009) Promotional spending for prescription drugs. Report, Congressional Budget Office, Washington, DC.Google Scholar
• Card D, Krueger AB (1994) Minimum wages and employment: A case study of the fast-food industry in New Jersey and Pennsylvania. Amer. Econom. Rev. 84(4):772–793.Google Scholar
• Card D, Krueger AB (2000) Minimum wages and employment: A case study of the fast-food industry in New Jersey and Pennsylvania [reply]. Amer. Econom. Rev. 90(5):1397–1420.Crossref, Google Scholar
• Carey CM, Lieber EM, Miller S (2015) Drug firms’ payments and physicians’ prescribing behavior in Medicare part D. Submitted September 21, http://dx.doi.org/10.2139/ssrn.2663681.Google Scholar
• Chen DL, Levonyan V, Reinhart SE, Taksler G (2016) Mandatory disclosure: Theory and evidence from industry–physician relationships. Submitted March 2, http://dx.doi.org/10.2139/ssrn.2740559.Google Scholar
• Chimonas S, Rozario NM, Rothman DJ (2010) Show us the money: Lessons in transparency from state pharmaceutical marketing disclosure laws. Health Services Res. 45(1):98–114.Crossref, Google Scholar
• DeJong C, Aguilar T, Tseng C-W, Lin GA, Boscardin WJ, Dudley RA (2016) Pharmaceutical industry–sponsored meals and physician prescribing patterns for Medicare beneficiaries. JAMA Internal Medicine 176(8):1114–1122.Crossref, Google Scholar
• Dube A, Lester TW, Reich M (2010) Minimum wage effects across state borders: Estimates using contiguous counties. Rev. Econom. Statist. 92(4):945–964.Crossref, Google Scholar
• Efron B, Tibshirani RJ (1994) An Introduction to the Bootstrap (CRC Press, New York).Crossref, Google Scholar
• Engelberg J, Parsons CA, Tefft N (2014) Financial conflicts of interest in medicine. Submitted July 23, http://dx.doi.org/10.2139/ssrn.2297094.Google Scholar
• Goldfarb A, Tucker CE (2014) Conducting research with quasi-experiments: A guide for marketers. Working paper No. 2420920, Rotman School of Management, Toronto.Google Scholar
• Grochowski Jones R, Ornstein C (2016) Matching industry payments to Medicare prescribing patterns: An analysis. ProPublica. Accessed October 31, 2016, https://projects. propublica. org/docdollars/.Google Scholar
• Guo T, Sriram S, Manchanda P (2017) The effect of information disclosure on industry payments to physicians. Submitted September 8, http://dx.doi.org/10.2139/ssrn.3064769.Google Scholar
• Holmes TJ (1998) The effect of state policies on the location of manufacturing: Evidence from state borders. J. Political Econom. 106(4):667–705.Crossref, Google Scholar
• Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. New England J. Medicine 345(11):790–797.Crossref, Google Scholar
• Inderst R, Ottaviani M (2012) Competition through commissions and kickbacks. Amer. Econom. Rev. 102(2):780–809.Crossref, Google Scholar
• Kesselheim AS, Robertson CT, Siri K, Batra P, Franklin JM (2013) Distributions of industry payments to Massachusetts physicians. New England J. Medicine 368(22):2049–2052.Crossref, Google Scholar
• King M, Bearman P (2013) Conflict of Interest Policies and the Diffusion of Stimulant, Antidepressant, and Antipsychotic Medications (American Sociological Association New York City).Google Scholar
• Loewenstein G, Cain DM, Sah S (2011) The limits of transparency: Pitfalls and potential of disclosing conflicts of interest. Amer. Econom. Rev. 101(3):423–428.Crossref, Google Scholar
• Manchanda P, Chintagunta PK (2004) Responsiveness of physician prescription behavior to salesforce effort: An individual level analysis. Marketing Lett. 15(2–3):129–145.Crossref, Google Scholar
• Manchanda P, Honka E (2009) The effects and role of direct-to-physician marketing in the pharmaceutical industry: An integrative review. Yale J. Health Policy Law Ethics 5(2):785–822.Google Scholar
• NCHS (2017) Health, United States, 2016, with chartbook on long-term trends in health. (Government Printing Office Hyattsville, MD).Google Scholar
• Perry JE, Cox D, Cox AD (2014) Trust and transparency: Patient perceptions of physicians’ financial relationships with pharmaceutical companies. J. Law Medical Ethics 42(4):475–491.Crossref, Google Scholar
• Pham-Kanter G, Alexander GC, Nair K (2012) Effect of physician payment disclosure laws on prescribing. Arch. Internal Medicine 172(10):819–821.Crossref, Google Scholar
• Salami JA, Warraich H, Valero-Elizondo J, Spatz ES, Desai NR, Rana JS, Virani SS, Blankstein R, Khera A, Baha MJ, et al.. (2017) National trends in statin use and expenditures in the US adult population from 2002 to 2013: Insights from the medical expenditure panel survey. JAMA Cardiology 2(1):56–65.Crossref, Google Scholar
• Santhakumar S, Adashi EY (2015) The physician payment sunshine act: Testing the value of transparency. JAMA 313(1):23–24.Crossref, Google Scholar
• Shapiro B (2018a) Informational shocks, off-label prescribing and the effects of physician detailing. Management Sci. 64(12):5925–5945.Link, Google Scholar
• Shapiro B (2018b) Positive spillovers and free riding in advertising of prescription pharmaceuticals: The case of antidepressants. J. Political Econom. 126(1):381–437.Crossref, Google Scholar
• Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC (2000) Primary prevention of coronary heart disease in women through diet and lifestyle. New England J. Medicine 343(1):16–22.Crossref, Google Scholar
• Tirunillai S, Tellis GJ (2017) Does offline TV advertising affect online chatter? Quasi-experimental analysis using synthetic control. Marketing Sci. 36(6):862–878.Link, Google Scholar
• Tucker C, Zhang J, Zhu T (2013) Days on market and home sales. RAND J. Econom. 44(2):337–360.Crossref, Google Scholar
• Xu Y (2017) Generalized synthetic control method: Causal inference with interactive fixed effects models. Political Anal. 25(1):57–76.Crossref, Google Scholar
• Yeh JS, Franklin JM, Avorn J, Landon J, Kesselheim AS (2016) Association of industry payments to physicians with the prescribing of brand-name statins in Massachusetts. JAMA Internal Medicine 176(6):763–768.Crossref, Google Scholar